David M Weinstock MD

PubMed

• Azacitidine-induced remission enables allogeneic transplantation in/-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.
  Carmen de Ramon Ortiz, Hana Abouzeid, Chiara De Bernardi, André Durham, Gregory Mathoux
  Haematologica. 2026-04-02
• Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy.
  Ran Xu, Gongwei Wu, Siobhan Rice, Matthew Booker, Jenalyn Celine Weekes
  Blood Advances. 2026-03-19
• Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.
  Ye Zhang, Lydie Debaize, Adam Langenbucher, Jenalyn Weekes, Ioulia Vogiatzi
  Science Advances. 2025-12-05

Journal Articles

• Clinicogenetic risk modeling in ATL  
  Yoshida N, Weinstock DM, Blood, 1/1/2018
• Outcomes After Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma  
  Herrera AF, Rodig, SJ, Song JY, Kim Y, Griffin GK, Yang D, Nikolaenko L, Mei M, Bedell V, Dal Cin P, Pak C, Alyea EP, Budde LE, Chen R, Chen Y-B, Chan WC, Cutler CS, H..., Biol Blood Marrow Transplant, 1/1/2018
• Activity of the PI3K-delta,gamma inhibitor Duvelisib in a phase I trial and preclinical models of T-cell lymphoma  
  Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, Myskowski P, Officer A, Jaffe JD, Morrow SN, Allen K, Douglas M, Stern H, Sweeney J, Kelly P, Kelly V, Aster ..., Blood, 1/1/2018

Books/Book Chapters

• Disaster Medicine: Comprehensive Principles and Practice 
  Chapter: Radiation accidents and the medical management of acute radiation injury 
  Page 545.0 - 579.0Hatchett RJ, Weinstock DM, Goans REEditors: Koenig and Schultz.Cambridge University Press, New York, NY2016
• Principles and Practices of Infectious Diseases 
  Chapter: Epstein-Barr Virus, Varicella-Zoster Virus and Human Herpes Viruses-6 and -8 
  Page 359.0 - 370.0Kamboj M, Weinstock DMEditors: Safdar A.Humana Press, New York, NY2011
• Multidrug-resistant tuberculosis 
  Chapter: Multidrug-resistant tuberculosis and the health care worker 
  Page 225.0 - 240.0Weinstock DM, Sepkowitz KAEditors: Bastian I, Portaels F.Kluwer Academic Publishers, Dordrecht, The Netherlands2000

Abstracts/Posters

• DT2216, a BCL-XL Proteolysis Targeting Chimera (PROTAC), Is a Potent Anti T-Cell Lymphoma Agent That Does Not Induce Significant Thrombocytopenia
  David M. Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Dynamic Assembly of a Feedback Complex to Regulate Oncogenic B-Cell Receptor-Signaling
  David M. Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Enhancer Rewiring Dependent Switch from BCL2 to MCL1 Dependency Predicts NOTCH1 Inhibition Response in T-ALL
  David M. Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Aggressive Lymphomas 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Forum on Patient-Derived Models: What�s Next 
  DFCI, Boston, MA - 1/1/2018
• Targeting vulnerabilities in lymphoid neoplasms 
  Waltham, MA, 2018; Boston University Medical Center, Boston, MA, 2018; Brigham and Women�s Hospital, - 1/1/2018

Other

• Modeling Human Immunity and Disease 
  Weinstock D, CellPress Webinar
  http://view6.workcast.net/register?cpak=6477842955389592&referrer=webinarpage
  1/1/2017
• Navigating Future Challenges in Lymphoma: A Map for the Road Ahead 
  LaCasce A, Weinstock DM, The Hematologist
  1/1/2015
• �Health care loans� for Hep C Cure 
  Andrew Lo, David Weinstock, Boston Globe
  1/25/2016